Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1578-2017.
Nu Skin announces a voluntary field action for Pharmanex BioGinkgo due to undeclared allergen; wheat.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1578-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Nu Skin Enterprises Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1578-2017.
Nu Skin Enterprises Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Nu Skin Enterprises Inc. Recall FAQ
Nu Skin Enterprises Inc. is the subject of a food safety report: Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets. The notice was published on February 13, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 40,158 units are potentially affected.